News

For surgeons, the decision goes beyond clarifying a patient’s vision.

Although graft rejection has not been associated with vaccinations, concern remains.

Impairment of corneal sensory innervation causes reduction of both protective reflexes and trophic neuromodulators that are essential for the vitality, metabolism, and wound healing of the ocular surface.

According to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation

Investigators say renal function could be used as a possible predictor for poor treatment response in certain patients with diabetic macular edema.

According to investigators, the virtual reality option could overcome hurdles associated with reliance on a physical course.

I-MED Pharma Inc., a Canadian-based firm, announced this week the expansion of its strategic partnership with ESW Vision in France to be their exclusive distributor in the United States.

TearLab Corp. announced that Adam Szaronos has been appointed president and CEO by the company's Board of Directors, effective immediately.

Under terms of the agreement, ImprimisRx to assume full responsibility for US sales and marketing activities for Dexycu.

According to the company, the board will support the advancement of late-stage ophthalmic assets Nyxol and APX3330.

Investigators are hopeful that future research can focus on public health concerns of dry eye disease.

Gift marks the first time the ACMG Foundation has allocated an award for training in ophthalmic genetics.

The company’s IOPerfect combines artificial intelligence in a VR-like headset to allow tele-diagnosis and remote monitoring of glaucoma.

The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022.

The agreement includes Europe, Commonwealth of Independent States countries, China, India, parts of Latin America and the Oceania countries.

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.

Researchers have now found that subjects who underwent cataract surgery had nearly 30% lower risk of developing dementia from any cause compared with those who did not.

Study shows statistically significant improvement for primary endpoint of bulbar conjunctival hyperemia for OTX-DED 0.2 mg and 0.3 mg formulations compared with vehicle hydrogel insert.

The approval will allow LensGen to move forward with the IDE pivotal trial with the ultimate goal of seeking premarket approval in the United States.

According to Sebastian B. Heersink, surgeons can perform several procedures with cataract surgery.

More than 200 medical associations, including the American Medical Association and the Medical Group Management Association, have co-signed a letter seeking Congressional action on the issue before the end of the year.

AMA President Gerald E. Harmon, MD, said in a statement that President Joe Biden’s pandemic plan will make communities safer amid an evolving pandemic and confirmed cases of the Omicron variant.

Omidria will become a key product in Rayner's ophthalmology franchise, which includes intraocular lenses, ophthalmic viscoelastic devices and dry eye treatments.

French investigators found that individuals over the age of 75 were not at an increased risk of having a myocardial infarction, stroke, or pulmonary embolism during the 14 days after receiving each of the Pfizer-BioNTech vaccine doses against the COVID-19 virus.

Prompt and adequate action is a key to facilitating the best recovery in patients.

Save the dates for this virtual interactive conference featuring top US ophthalmologists